10-Year Check-In: could HPV fingerprints predict anal cancer?

NCT ID NCT06522256

Recruiting now Knowledge-focused Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows up with 100 men who took part in the ANRS IPERGAY HIV prevention trial to see how many have developed high-grade anal lesions or anal cancer a decade later. Researchers will use a special test to look for HPV mutations and viral DNA integration in the body. The goal is to better understand which HPV infections are most likely to lead to cancer, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anal carcinoma anus neoplasm human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANAL CANCER HPV INFECTION

Contacts and locations

Locations

Hôpital Saint-Louis - SMIT
RECRUITING

Paris, 75010, France
Hôpital Tenon - SMIT
RECRUITING

Paris, 75020, France
Hôpital de la Croix Rousse - SMIT
RECRUITING

Lyon, 69004, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.